Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I(492 views) Sasaki T, Ito H, Kimura Y, Arakawa R, Takano H, Seki C, Kodaka F, Fujie S, Takahata K, Nogami T, Suzuki M, Fujiwara H, Takahashi H, Nakao R, Fukumura T, Varrone A, Halldin C, Nishikawa T, Suhara T
Keywords: 18f-Fe-Pe2i, Dopamine Transporter, Kinetic Modeling, Positron Emission Tomography, Radiometabolite, Drug Metabolite, N (3 Iodoprop 2 Enyl) 2beta Carbofluoroethoxy 3beta (4 Methylphenyl)nortropane F 18, Radioligand, Unclassified Drug, Article, Brain Metabolism, Caudate Nucleus, Cerebellum, Compartment Model, Corpus Striatum, Distribution Volume, Drug Blood Level, Drug Uptake, Human, Human Experiment, Ligand Binding, Mesencephalon, Normal Human, Priority Journal, Putamen, Quantitative Analysis, Radioactivity, Thalamus, Adult, Algorithms, Brain Chemistry, Chromatography, High Pressure Liquid, Dopamine Plasma Membrane Transport Proteins, Image Processing, Computer-Assisted, Injections, Intravenous, Lipids, Positron-Emission Tomography, Radiopharmaceuticals, Young Adult, N (3 Iodoprop 2 Enyl) 2beta Carbofluoroethoxy 3beta (4 Methylphenyl) Nortropane F 18,
Affiliations: *** IBB - CNR ***
Molecular Neuroimaging Program, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan
Department of Psychiatry and Behavioral Sciences, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
Biophysics Program, Molecular Imaging Center, National Institute of Radiological Sciences, 4-9-1, Anagawa, Inage-ku, Chiba, 263-8555, Japan
Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Hospital, Stockholm, Sweden
Molecular Probe Program, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan
References: Hurley, M.J., Mash, D.C., Jenner, P., Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR (2003) European Journal of Neuroscience, 18 (9), pp. 2668-2672. , DOI 10.1046/j.1460-9568.2003.02963.
Ginovart, N., Lundin, A., Farde, L., Halldin, C., Backman, L., Swahn, C.-G., Pauli, S., Sedvall, G., PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease (1997) Brain, 120 (3), pp. 503-514. , DOI 10.1093/brain/120.3.503
Jucaite, A., Fernell, E., Halldin, C., Forssberg, H., Farde, L., Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: Association between striatal dopamine markers and motor hyperactivity (2005) Biological Psychiatry, 57 (3), pp. 229-238. , DOI 10.1016/j.biopsych.2004.11.009, PII S0006322304011679
Nakamura, K., Sekine, Y., Ouchi, Y., Brain serotonin and dopamine transporter bindings in adults with high-functioning autism (2010) Arch Gen Psychiatry, 67, pp. 59-68
Arakawa, R., Ichimiya, T., Ito, H., Increase in thalamic binding of [11C]PE2I in patients with schizophrenia: A positron emission tomography study of dopamine transporter (2009) J Psychiatr Res, 43, pp. 1219-1223
Fowler, J.S., Volkow, N.D., Wolf, A.P., Dewey, S.L., Schlyer, D.J., MacGregor, R.R., Hitzemann, R., Christman, D., Mapping cocaine binding sites in human and baboon brain in vivo (1989) Synapse, 4 (4), pp. 371-377. , DOI 10.1002/syn.890040412
Wong, D.F., Yung, B., Dannals, R.F., Shaya, E.K., Ravert, H.T., Chen, C.A., Chan, B., Kuhar, M.J., In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428 (1993) Synapse, 15 (2), pp. 130-142. , DOI 10.1002/syn.890150205
Ding, Y.S., Fowler, J.S., Volkow, N.D., Pharmacokinetics and in vivo specificity of [11C]dl-threo- methylphenidate for the presynaptic dopaminergic neuron (1994) Synapse, 18, pp. 152-160
Fischman, A.J., Bonab, A.A., Babich, J.W., [11C, 127I] Altropane: A highly selective ligand for PET imaging of dopamine transporter sites (2001) Synapse, 39, pp. 332-342
Laakso, A., Bergman, J., Haaparanta, M., Vilkman, H., Solin, O., Hietala, J., [18F]CFT [18F]WIN 35,428, a radioligand to study the dopamine transporter with PET: Characterization in human subjects (1998) Synapse, 28, pp. 244-250
Kazumata, K., Dhawan, V., Chaly, T., Antonini, A., Margouleff, C., Belakhlef, A., Neumeyer, J., Eidelberg, D., Dopamine transporter imaging with fluorine-18-FPCIT and PET (1998) Journal of Nuclear Medicine, 39 (9), pp. 1521-1530
Davis, M.R., Votaw, J.R., Douglas, B.J., Byas-Smith, M.G., Faber, T.L., Voll, R.J., Hoffman, J.M., Goodman, M.M., Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT (2003) Journal of Nuclear Medicine, 44 (6), pp. 855-861
Emond, P., Garreau, L., Chalon, S., Boazi, M., Caillet, M., Bricard, J., Frangin, Y., Guilloteau, D., Synthesis and ligand binding of nortropane derivatives: N-substituted 2beta-carbomethoxy-3beta-(4′-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)- 2beta-carbomethoxy-3beta-(3′,4′- disubstituted phenyl)nortropane. New high- affinity and selective compounds for the dopamine transporter (1997) Journal of Medicinal Chemistry, 40 (9), pp. 1366-1372. , DOI 10.1021/jm960795d
Halldin, C., Erixon-Lindroth, N., Pauli, S., [11C]PE2I: A highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain (2003) Eur J Nucl Med Mol Imaging, 30, pp. 1220-1230
Jucaite, A., Odano, I., Olsson, H., Pauli, S., Halldin, C., Farde, L., Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: A PET study (2006) Eur J Nucl Med Mol Imaging, 33, pp. 657-668
Hirvonen, J., Johansson, J., Teras, M., Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: Quantitative modeling and test-retest reproducibility (2008) J Cereb Blood Flow Metab, 28, pp. 1059-1069
Seki, C., Ito, H., Ichimiya, T., Quantitative analysis of dopamine transporters in human brain using [11C]PE2I and positron emission tomography: Evaluation of reference tissue models (2010) Ann Nucl Med, 24, pp. 249-260
Shetty, H.U., Zoghbi, S.S., Liow, J.-S., Ichise, M., Hong, J., Musachio, J.L., Halldin, C., Pike, V.W., Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C]PE2I (2007) European Journal of Nuclear Medicine and Molecular Imaging, 34 (5), pp. 667-678. , DOI 10.1007/s00259-006-0277-1
Varrone, A., Steiger, C., Schou, M., In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand (2009) Synapse, 63, pp. 871-880
Varrone, A., Toth, M., Steiger, C., Kinetic analysis and quantification of the dopamine transporter in the nonhuman primate brain with11C-PE2I and18F-FEPE2I (2011) J Nucl Med, 52, pp. 132-139
Schou, M., Steiger, C., Varrone, A., Guilloteau, D., Halldin, C., Synthesis, radiolabeling and preliminary in vivo evaluation of [ 18F]FE-PE2I, a new probe for the dopamine transporter (2009) Bioorg Med Chem Lett, 19, pp. 4843-4845
Innis, R.B., Cunningham, V.J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R.N., Holden, J., Carson, R.E., Consensus nomenclature for in vivo imaging of reversibly binding radioligands (2007) Journal of Cerebral Blood Flow and Metabolism, 27 (9), pp. 1533-1539. , DOI 10.1038/sj.jcbfm.9600493, PII 9600493
Leenders, K.L., Perani, D., Lammertsma, A.A., Heather, J.D., Buckingham, P., Healy, M.J.R., Gibbs, J.M., Jones, T., Cerebral blood flow, blood volume and oxygen utilization: normal values and effect of age (1990) Brain, 113 (1), pp. 27-47
Hall, H., Halldin, C., Guilloteau, D., Chalon, S., Emond, P., Besnard, J.-C., Farde, L., Sedvall, G., Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [125I]PE2I (1999) NeuroImage, 9 (1), pp. 108-116. , DOI 10.1006/nimg.1998.0366
Lammertsma, A.A., Hume, S.P., Simplified reference tissue model for PET receptor studies (1996) Neuroimage., 4, pp. 153-158
Akaike, H., A new look at the statistical model identification (1974) IEEE Trans Automat Contr, 19, pp. 716-723
Carson, R., Parameters estimation in positron emission tomography (1986) Positron Emission Tomography Principle Applications for the Brain and the Heart, pp. 347-390. , Phelps M, Mazziotta J, Schelbert H, eds. New York, NY: Raven Press
Seneca, N., Skinbjerg, M., Zoghbi, S.S., Kinetic brain analysis and whole-body imaging in monkey of [ 11C]MNPA: A dopamine agonist radioligand (2008) Synapse, 62, pp. 700-709
Terry, G., Liow, J.S., Chernet, E., Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents (2008) Neuroimage., 41, pp. 690-698
Parsey, R.V., Slifstein, M., Hwang, D.R., Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: Comparison of arterial and reference tisssue input functions (2000) J Cereb Blood Flow Metab, 20, pp. 1111-1133
Varrone, A., Gulyas, B., Takano, A., Stabin, M.G., Jonsson, C., Halldin, C., Simplified quantification and whole-body distribution of [ 18F]FE-PE2I in nonhuman primates: Prediction for human studies (2012) Nucl Med Biol, 39, pp. 295-303
Hurley, M. J., Mash, D. C., Jenner, P., Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR (2003) European Journal of Neuroscience, 18 (9), pp. 2668-2672. , DOI 10. 1046/j. 1460-9568. 2003. 02963.
Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., Hitzemann, R., Christman, D., Mapping cocaine binding sites in human and baboon brain in vivo (1989) Synapse, 4 (4), pp. 371-377. , DOI 10. 1002/syn. 890040412
Wong, D. F., Yung, B., Dannals, R. F., Shaya, E. K., Ravert, H. T., Chen, C. A., Chan, B., Kuhar, M. J., In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C] WIN 35, 428 (1993) Synapse, 15 (2), pp. 130-142. , DOI 10. 1002/syn. 890150205
Ding, Y. S., Fowler, J. S., Volkow, N. D., Pharmacokinetics and in vivo specificity of [11C] dl-threo- methylphenidate for the presynaptic dopaminergic neuron (1994) Synapse, 18, pp. 152-160
Fischman, A. J., Bonab, A. A., Babich, J. W., [11C, 127I] Altropane: A highly selective ligand for PET imaging of dopamine transporter sites (2001) Synapse, 39, pp. 332-342
Davis, M. R., Votaw, J. R., Douglas, B. J., Byas-Smith, M. G., Faber, T. L., Voll, R. J., Hoffman, J. M., Goodman, M. M., Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT (2003) Journal of Nuclear Medicine, 44 (6), pp. 855-861
Shetty, H. U., Zoghbi, S. S., Liow, J. -S., Ichise, M., Hong, J., Musachio, J. L., Halldin, C., Pike, V. W., Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C] PE2I (2007) European Journal of Nuclear Medicine and Molecular Imaging, 34 (5), pp. 667-678. , DOI 10. 1007/s00259-006-0277-1
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Carson, R. E., Consensus nomenclature for in vivo imaging of reversibly binding radioligands (2007) Journal of Cerebral Blood Flow and Metabolism, 27 (9), pp. 1533-1539. , DOI 10. 1038/sj. jcbfm. 9600493, PII 9600493
Leenders, K. L., Perani, D., Lammertsma, A. A., Heather, J. D., Buckingham, P., Healy, M. J. R., Gibbs, J. M., Jones, T., Cerebral blood flow, blood volume and oxygen utilization: normal values and effect of age (1990) Brain, 113 (1), pp. 27-47
Parsey, R. V., Slifstein, M., Hwang, D. R., Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C] WAY-100635 in humans: Comparison of arterial and reference tisssue input functions (2000) J Cereb Blood Flow Metab, 20, pp. 1111-1133
Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(496 views) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 ViewExport to BibTeXExport to EndNote
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R * 3. 0 T perfusion MR imaging(726 views) Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812. Impact Factor:0.023 ViewExport to BibTeXExport to EndNote